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Following damage to peripheral nerves, a remarkable
process of clearance and regeneration takes place.
Axons downstream of the injury degenerate, while
the nerve is remodeled to direct axonal regrowth.
Schwann cells are important for this regenerative
process. ‘‘Sensing’’ damaged axons, they dediffer-
entiate to a progenitor-like state, in which they aid
nerve regeneration. Here, we demonstrate that acti-
vation of an inducible Raf-kinase transgene in mye-
linated Schwann cells is sufficient to control this
plasticity by inducing severe demyelination in the
absence of axonal damage, with the period of
demyelination/ataxia determined by the duration of
Raf activation. Remarkably, activation of Raf-kinase
also induces much of the inflammatory response
important for nerve repair, including breakdown of
the blood-nerve barrier and the influx of inflammatory
cells. This reversible in vivo model identifies a central
role for ERK signaling in Schwann cells in orches-
trating nerve repair and is a powerful system for
studying peripheral neuropathies and cancer.
INTRODUCTION
Peripheral nerves are complex structures consisting of motor,
sensory and autonomic neurons, which connect tissues and
organs to the central nervous system (CNS). Within the nerves,
the axons of individual neurons are intimately associated with
the major glia of the peripheral nervous system (PNS), Schwann
cells. Larger axons associate in a 1:1 fashion with myelinating
Schwann cells, whereas nonmyelinating Schwann cells bundle
smaller axons together in structures known as Remak bundles.
Groups of Schwann cell-enwrapped axons are further bundled
into structures known as fascicles by perineural fibroblasts,
and large nerves consist of several of these fascicles wrapped
by the epineurium. Like the CNS, the PNS is a privileged environ-
ment, with specialized blood vessels within the nerve maintain-ing a blood-nerve barrier (BNB) (Choi and Kim, 2008). Despite
their complex structure, peripheral nerves are one of the few
mammalian tissues with the capacity for extensive regeneration.
Following a nerve injury, axons downstream of the damage
degenerate in an active process known as Wallerian degen-
eration. The associated Schwann cells dedifferentiate to a
progenitor-like state and proliferate and, together with infiltrating
macrophages, clear the axonal and myelin debris. This period
is associated with a robust inflammatory response: the BNB
is breached and inflammatory cells enter the nerve in large
numbers—both at the damage site and throughout the length
of the distal stump. The axons regrow from upstream of the
site of damage using ‘‘tubes’’ of progenitor-like Schwann cells,
which remain within their basal lamina, to guide them back to
their original target tissues. The Schwann cells then redifferenti-
ate to fully restore nerve function and the inflammatory response
resolves (Stoll et al., 2002; Zochodne, 2008).
Several pathologies have been linked to aberrations in this
repair process. Neurofibromas, the major tumor type of this
tissue, are most frequently seen in patients with the common
genetic disorder neurofibromatosis type 1 (NF1). These tumors
are often referred to as ‘‘unrepaired wounds,’’ as they consist
of a mixture of progenitor-like Schwann cells, dissociated from
axons, infiltrated by large numbers of inflammatory cells, which
have been reported to have an important role in tumor develop-
ment (Parrinello and Lloyd, 2009). Similarly, many peripheral
neuropathies are associated with demyelination and frequently
an inflammatory response (Stoll et al., 2002; Suter and Scherer,
2003). However, despite the importance of understanding the
regenerative nature of this tissue and important implications
for disease, the molecular nature of the response, and how
the complex cellular processes are coordinated remain poorly
understood.
We have previously shown that activation of the Raf/MEK/ERK
signaling pathway is sufficient to induce dedifferentiation of
myelinated Schwann cells in vitro (Harrisingh et al., 2004). More-
over, we and others have shown that there is a rapid and robust
activation of ERK signaling in Schwann cells following nerve
injury, both at the injury site and throughout the distal stump
(Harrisingh et al., 2004; Sheu et al., 2000). Interestingly, high
levels of ERK activity have also been observed in Schwann
cells in models of both inherited and infectious peripheralNeuron 73, 729–742, February 23, 2012 ª2012 Elsevier Inc. 729
Figure 1. The Raf/ERK Pathway Is Specifically
Activated in Schwann Cells in P0-RafTR Trans-
genic Mice
(A) Schematic illustrations of the Ras/Raf/MEK/ERK
pathway and of a Schwann cell in the P0-RafTR transgenic
mice. The Raf kinase/estrogen receptor fusion protein is
expressed under the control of the Schwann cell spe-
cific P0 promoter in an inactive state. In the presence of
tamoxifen, RafTR is activated and stimulates the ERK
signaling pathway.
(B) Western blot analysis of RafTR protein expression (ER)
and ERK activation (P-ERK) following tamoxifen injection.
Left panel: protein lysates from CNS (cerebral cortex-C)
and PNS (sciatic nerve-S) of WT and P0-RafTR mice,
noninjected or 24 hr post-tamoxifen injection. Right panel:
‘‘uncut’’ and ‘‘cut’’ nerve extracts from WT sciatic nerves
24 hr postsurgery and P0-RafTR and WT sciatic nerve
lysates, 24 hr post-Tmx injection.
(C) Confocal images of longitudinal or cross-sections of
sciatic nerve immunostained for P-ERK (red) and the
myelin protein P0 (green) in WT (a–d) and P0-RafTR (e–h)
tamoxifen-injected mice; (c and d) and (g and h) show
zoomed regions of (b) and (f). Scale bar is 25 mm (a, b, e,
and f) and 10 mm (c, d, g, and h).
See also Figure S1.
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Raf/MEK/ERK Drives Schwann Cell Demyelinationneuropathies (Fischer et al., 2008; Nadra et al., 2008; Tapinos
et al., 2006). Moreover, ERK activation occurs in Schwann cell
tumors that arise in NF1, as a result of excessive Ras signaling
secondary to the loss of the Ras-GAP neurofibromin that is
encoded by NF1 (McClatchey, 2007). However, recent mouse
models of NF1 have indicated that neurofibromin loss is unable
to drive Schwann cell dedifferentiation in the adult nerve (Joseph
et al., 2008; Wu et al., 2008; Zheng et al., 2008), and other sig-
naling pathways have been linked to the dedifferentiation pro-
cess (Jessen andMirsky, 2008; Parkinson et al., 2008; Woodhoo
et al., 2009), leading to speculation that a single signaling path-
way may be insufficient to drive the dedifferentiation process in
the context of a fully functional adult nerve.
To address these issues we constructed a transgenic mouse
which, by targeting a tamoxifen (Tmx)-inducible Raf-kinase/
estrogen receptor fusion protein (RafTR) specifically to myeli-
nating Schwann cells, enabled us to rapidly and reversibly acti-
vate the Raf/MEK/ERK signaling pathway in adult myelinating
Schwann cells—permitting a temporal analysis of the effects of
activating Raf/MEK/ERK signaling in Schwann cells in vivo. We
found that activation of Raf-kinase was sufficient to drive the
dedifferentiation of myelinating Schwann cells to a progenitor-
like state in peripheral adult nerves, resulting in severe loss of
motor function. Importantly, the demyelinated phenotype was
independent of axonal degradation—the normal injury signal—
but was instead determined by the period of ERK activation,
with rapid remyelination and neurological recovery taking place
following the withdrawal of tamoxifen. Interestingly, despite the
absence of injury, Raf activation in Schwann cells resulted in730 Neuron 73, 729–742, February 23, 2012 ª2012 Elsevier Inc.the breakdown of the BNB and the recruitment
of inflammatory cells, a response mimicked
by the activation of Raf/MEK/ERK signaling in
Schwann cells in vitro. Our results identify theSchwann cell as a central organizer of the complex cellular
response required for peripheral nerve repair and the Raf/MEK/
ERK signaling pathway as the key intracellular mediator of these
responses.
RESULTS
To address the role of the Raf/MEK/ERK signaling pathway
in vivo, we developed an inducible transgenic mouse-model
system that allowed us to regulate ERK signaling in myelinating
Schwann cells in the adult. To do this, we expressed a tamoxifen
(Tmx)—inducible Raf-kinase/estrogen receptor fusion protein
(RafTR) (Samuels et al., 1993) under the control of a myelinating
Schwann cell-specific promoter (Figure 1A). The expression of
this fusion protein allows the rapid and reversible activation
of Raf kinase activity and the downstream MEK/ERK kinase
cascade following the addition of hormone (Figure 1A). To ensure
robust expression, we used a modified rat myelin protein zero
(P0) promoter containing intronic and non-translated 30 and 50
elements of the human connexin-32 gene, which has previously
been shown to enhance expression in myelinated Schwann cells
(Figure 1A and see Figure S1 available online; Huang et al., 2005;
Scherer et al., 2005). This construct should direct the expression
of inactive RafTR protein in these cells throughout the PNS. The
RafTR fusion protein contains a point mutation in the human
estrogen receptor ligand-binding domain, so that it can be acti-
vated by the injection of the estrogen analog tamoxifen but
not by endogenous estrogens. Following pronuclear injection
of the linearized construct, we obtained 8 RafTR-positive mice,
Figure 2. Raf Activation in Schwann Cells Causes
a Severe Loss of Motor Function; Myelin Gene
Expression Is Downregulated
(A) Schematic illustration of the protocol used for tamox-
ifen injections. P0-RafTR but not WT mice exhibit severe
motor function defects by day 10, with abnormal hind-limb
posture following tamoxifen injections.
(B) WT and P0-RafTR adult mice were tested using an
accelerating rotarod for a maximum of 300 s on day 10.
Mean latency to fall (in seconds, ± SEM) is plotted (n = 10
animals for each group). See also Movies S1 and S2.
(C) qRT-PCR analysis of RNA from sciatic nerves of WT
and P0-RafTR mice, after 72 hr of daily tamoxifen injec-
tions. The bar graphs represent the relative transcript
levels of indicated genes (n = 4 animals for each group,
data are represented as mean values ± SEM).
(D) Representative phase-microscopy images of semi-thin
cross-sections of sciatic nerves from WT and P0-RafTR
mice stained with toluidine blue after 72 hr of daily
tamoxifen injections (top panels). Scale bar is 20 mm.
Longitudinal sections of sciatic nerves stained for neuro-
filament (red) and nuclei stained with Hoechst (blue). Scale
bar is 50 mm (bottom panels).
(E) Quantification of myelinated fibers inWT and P0-RafTR
mice at day 3 (n = 3 animals for each group, 3 different
fields were counted for each animal, data are represented
as mean values ± SEM).
See also Figure S2.
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mRNA and protein in sciatic nerve. The RafTR-expressing mice
were crossed with wild-type (WT) animals, and in all subsequent
experiments heterozygous P0-RafTR mice were compared with
their WT, age-matched littermates. Similar results were obtained
with both P0-RafTR lines.
To confirm the specificity of expression of the construct and
the inducibility of the Raf-kinase activity, we initially gave the
mice a single intraperitoneal (IP) injection of tamoxifen and
analyzed the mice after 24 hr. As controls, we compared the in-
jected P0-RafTR mice to both uninjected P0-RafTR mice and to
tamoxifen-injected WT controls. Western blot analysis detected
the RafTR protein in peripheral nerve extracts from P0-RafTR
mice but not in WT controls (Figure 1B). Moreover, the fusion
protein could not be detected in cortical brain extracts, confirm-
ing the specificity of expression. Levels of RafTR protein were
higher in the injected animals compared to uninjected RafTR-Neuron 73, 729expressing controls, which is consistent with
the reported stabilization of the protein upon
tamoxifen binding. Importantly, Raf-kinase ac-
tivity, as measured by the level of the phosphor-
ylated downstream effector ERK (P-ERK), was
induced in the PNS but not the CNS following
tamoxifen injection (Figure 1B). Increased levels
of P-ERK were not detectable in either WT
animals injected with tamoxifen or uninjected
P0-RafTR animals, confirming the tight re-
gulation of the Raf kinase in the mouse. Immu-
nolabeling of sciatic nerves demonstrated that
ERK was activated specifically in myelinated
Schwann cells following tamoxifen injection,confirming the inducible nature of the kinase in the intended
target cells (Figure 1C). The magnitude of P-ERK induction was
similar to that seen in the distal stump of cut WT sciatic nerves
24 hr following nerve transection, indicating that we are acti-
vating the ERK pathway in P0-RafTR nerves to levels similar to
those seen following an injury response in WT nerves (Figures
1B, 1C, and S1B).
Following injury, high levels of P-ERK are rapidly induced in
myelinating Schwann cells and persist for 3–5 days (Harrisingh
et al., 2004). To mimic this, control and transgenic mice (aged
4–6 weeks) were given 5 consecutive daily IP tamoxifen injec-
tions and their behavior was monitored daily. In control animals,
the injections had no observable effect. In contrast, at day 7–8
we noticed the animals were weaker and by day 10, the
P0-RafTR mice displayed severe impairment of coordination
and positioning of their limbs, consistent with a demyelinating
phenotype (Figure 2A). In some cases, the effects were so severe–742, February 23, 2012 ª2012 Elsevier Inc. 731
Figure 3. Raf Activation in Schwann Cells Drives PNS Demyelination
in the Absence of Axonal Injury
(A) qRT-PCR analysis of RNA from sciatic nerves of WT and P0-RafTR mice
10 days after the first tamoxifen injection (day 10) when transgenic mice exhibit
severe motor dysfunction. The bar graphs represent the relative transcript
levels of indicated genes ± SEM (n = 4 for each group).
(B) Representative images of sciatic nerve sections from WT and P0-RafTR
mice on day 10. Left panel: phase-contrast images of toluidine blue stained,
semi-thin cross-sections. Scale bar is 20 mm. Middle panels: longitudinal
sections immunolabeled for neurofilament (red) and nuclei stained with
Hoechst (blue). Scale bar 50 mm. Right panels: cross-sections immunolabeled
for p75 (green); scale bar 250 mm. Four animals were examined for each
condition and all animals showed a similar phenotype.
(C) Electron micrographs showing examples of demyelination in P0-RafTR
mice sciatic nerve. Scale bar 5 mm.
(D) Quantification of myelinated fibers in WT and P0-RafTR mice at day 10
(n = 4 animals for each group, 3 different fields were counted for each animal
and data are represented as mean values ± SEM).
See also Figure S3.
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(Movie S1). Hind-paw prints from injected P0-RafTR mice
were more elongated and had reduced ‘‘toespread’’ compared
to injected WT littermates (Figure S2)—signs indicative of
peripheral nerve damage (Crawley, 2008). Furthermore, a large
impairment in motor coordination was observed as measured
by the accelerating rotarod test (Movie S2); and quantified in Fig-
ure 2B. These results show that Raf-kinase activation in myelin-
ated Schwann cells is sufficient to drive a rapid loss of peripheral
nerve function in vivo, consistent with nerve demyelination.
Our previous in vitro studies have shown that Raf/MEK/ERK
driven Schwann cell dedifferentiation is associated with the
downregulation of myelin-specific gene expression and the up-
regulation of genes expressed by dedifferentiated Schwann cells
(Harrisingh et al., 2004). Quantitative RT-PCR analysis of nerves
isolated from tamoxifen-injected P0-RafTR animals showed that
by day 3 following the first injection (day 3) the expression of
myelin genes were strongly downregulated. (Figure 2C). Con-
versely, markers of dedifferentiated Schwann cells in the adult,
Krox-24 and p75 (also expressed by nonmyelinating Schwann
cells), together with the proliferation marker cyclin D1, were
strongly upregulated (Figure 2C). However, analysis of sciatic
nerves from these mice showed that at day 3, the structure of
the nerves was indistinguishable from that of WT injected
animals, with no differences in the degree of myelination (Figures
2D and 2E), demonstrating that changes in gene expression
occurred prior to myelin breakdown. Moreover, axonal staining
showed that the axons remained intact (Figure 2D).
The downregulation of myelin gene expression observed
on day 3 was sustained in the nerves of transgenic mice on
day 10, when the motor dysfunction was severe (Figure 3A).
However, when the structure of peripheral nerves was analyzed
at this time, a dramatic change in histology was observed:
most notably, there was widespread breakdown of myelin
and increased cellularity in the intraneural spaces (Figures 3B
and 3C). Quantification of the extent of demyelination confirmed
a large decrease in the number of Schwann cell/axon units con-
taining compact myelin (Figure 3D) and many of the remaining
units displayed myelin infoldings and outfoldings together with
vacuoles of degraded myelin protein, which are characteristic
of demyelination in injured nerves. Immunostaining of the nerve
showed a large increase in the number of p75-positive cells,
confirming that these cells had dedifferentiated back to a
progenitor-like state (Figure 3B). Interestingly, despite the
breakdown of the myelin sheaths and the dedifferentiation of
the Schwann cells, the axons remained intact, as determined
by EM, neurofilament staining and that the levels of neuronal-
specific tau mRNA levels remained unchanged (Figures 3A,
3B, and S3A–S3C). In contrast, at similar time points following
nerve damage, only minor fragments of axonal debris remained
within the nerve and neurofilament protein was no longer detect-
able (Figure S3B). Although the degree of demyelination was
severe in the P0-RafTR mice, it was not complete, as some
axons were still myelinated. To determine whether the incom-
plete phenotype was due to insufficient levels of tamoxifen
throughout the nerve, we performed intraneural injections of
tamoxifen into several P0-RafTR and control mice (Figure S3D).
Consistent with this hypothesis, we found complete demyelin-732 Neuron 73, 729–742, February 23, 2012 ª2012 Elsevier Inc.ation of nerves in the proximity of the injection site. Importantly,
this occurred in the absence of observable axonal damage and
the structure of the nerve was normal in sections far from the
injection site (Figures S3E and S3F). Thus, activation of Raf-
kinase activity in myelinating Schwann cells is sufficient to drive
Schwann cell dedifferentiation in adult nerve without causing
axonal damage.
Figure 4. Increased Schwann Cell Proliferation in
Demyelinated P0-RafTR Nerves
(A) Electron micrographs of cross-sections of WT and P0-
RafTR mice at day 10. Note the increased number of cells
(yellow arrows) and collagen deposition. Scale bar is 5 mm.
(B) Cryosections of WT and P0-RafTR mice at indicated
time-points following tamoxifen treatment were stained
with Hoechst and P75 antibody to label Schwann cells.
Graphs show quantification of nuclei (LHS) and p75-
positive cells (RHS) per field of view at the indicated time
points (n = 4 animals for each group at each time point,
8 different fields were counted for each animal, data are
represented as mean values ± SEM).
(C) WT and P0-RafTR mice were injected with EdU, 4 hr
prior to sacrifice. Left panel: representative images of EdU
labeling (red) of WT and P0-RafTR mice costained for p75
(green) at day 5. Scale bar 10 mm. Right panel: quantifi-
cation of the percentage of EdU positive cells (upper
graph) and the percentage of EdU-positive cells that are
P75 positive (proliferating Schwann cells) (lower graph) in
WT and RafTR sciatic nerves at indicated time points (n = 3
animals for each group at each time point, 8 different fields
were counted for each animal, data are represented as
mean values ± SEM).
See also Figure S4.
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cells in the context of a normal nerve allows us to determine
the role of this specific signaling pathway in Schwann cells in
the broader inflammatory and regenerative response to injury.
EM examination of the nerves from P0-RafTR animals fol-
lowing tamoxifen injection, revealed an increase in the size of
the collagen-rich spaces between Schwann cell/axon units,
which contained cells that were not present in control nerves
(Figure 4A) and quantification confirmed this increase in cell
number (Figure 4B). We also observed a large increase in p75-
positive cells, presumably largely due to the dedifferentiation of
myelinating cells to a progenitor-like state (Figure 4B). Moreover,
proliferation markers showed there was considerably more
proliferation in the nerves from injected P0-RafTR mice
compared to controls and that a significant proportion of these
proliferating cells were Schwann cells (Figures 4C and S4).
When peripheral nerves are injured, inflammatory cells are
recruited to the injury site and throughout the distal stump where
they aid in the clearance of myelin debris—a prerequisite for effi-
cient nerve regeneration (Chen et al., 2007). Following a physical
trauma, chemoattractants are released which attract inflam-
matory cells. Naked axons, myelin debris, and dedifferentiated
Schwann cells have all been proposed as potential sources of
such inflammatory signals (MacDonald et al., 2006; MartiniNeuron 73, 729et al., 2008). As aberrant inflammatory re-
sponses have been linked both to peripheral
neuropathies and the development of peripheral
nerve tumors, it is important to determine the
cellular and molecular basis of these responses
(Martini et al., 2008; Meyer zu Ho¨rste et al.,
2007; Parrinello and Lloyd, 2009; Staser et al.,
2010). To address whether Raf/MEK/ERK sig-
naling in Schwann cells is involved in the recruit-ment of inflammatory cells, we compared P0-RafTR nerves to
control nerve sections using a panel of inflammatory cell markers
(Figures 5 and S5). Remarkably, in nerves from injected P0-
RafTRmice, we observed a large increase in the number of mac-
rophages, mast cells, neutrophils, and T cells, all of which have
been shown to be recruited into nerves following injury (Figures
5A–5E and S5A–S5C). These results were confirmed by analysis
of EM sections, where large numbers of macrophages and mast
cells could be seen (Figures 5A and S5C). However, one cell
type, fibroblasts, which are found in large numbers in damaged
nerves were not recruited into P0-RafTR nerves following tamox-
ifen injection (Figure S5D), suggesting that Schwann cells may
not be responsible for recruiting fibroblasts to damaged nerves.
Interestingly, the influx of inflammatory cells mirrored the re-
sponse seen following an injury, with neutrophils entering the
nerve at day 3, followed by macrophages, mast cells and T cells
at around day 5 with the numbers increasing over time (Hall,
2005; Mueller et al., 2003). Importantly, at day 5, there was no
observable myelin breakdown—suggesting that signals from
dedifferentiated Schwann cells, rather than axons or myelin
debris, are responsible for recruiting inflammatory cells.
The simplest explanation for our findings is that substances
secreted by Raf-activated Schwann cells were directly respon-
sible for the inflammatory response.We therefore testedwhether–742, February 23, 2012 ª2012 Elsevier Inc. 733
Figure 5. Inflammatory Cells Are Rapidly Re-
cruited into Peripheral Nerves following Raf Acti-
vation in Schwann Cells
(A) Left panel: representative images of sciatic nerve
cross-sections immunolabeled for the macrophage
marker, Iba1 (red) and nuclei stained with Hoechst (blue).
Scale bar is 25 mm. Right panel: an electron micrograph
image showing a macrophage in the P0-RafTR sciatic
nerve. Scale bar is 5 mm.
(B) Quantification of macrophage number as determined
by Iba1/Hoechst staining of sciatic nerve cryosections for
indicated time points in tamoxifen treated control WT and
P0-RafTR mice.
(C–E) Similar quantification with antibodies specific to the
(C) mast cell marker CD117; (D) neutrophil marker NIMP-
R14 and (E) T cells marker CD3. (For all experiments: n = 3
animals for each group at each time point, 8 different fields
for each animal were counted, data are represented as
mean values ± SEM).
See also Figure S5.
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Schwann cells expressing the RafTR (NSRafER) (Lloyd et al.,
1997) was able to attract inflammatory cells in a similar fashion
to that seen in vivo. We collected blood from adult rats, purified
the white blood cell fraction and found that CM from tamoxifen-
treated cells attracted significantly more monocytes, T cells, and
granulocytes compared to vehicle-treated controls (Figures 6A
and S6A). Moreover, this response was dependent on signaling
through the ERK pathway confirming the specificity of the re-
sponse. In contrast, CM from tamoxifen-treated cells was unable
to attract more fibroblasts suggesting that cytokines produced
by dedifferentiated Schwann cells do not promote fibroblast
attraction which is consistent with the lack of a fibroblast re-
sponse in the RafTR nerves (Figure 6A).
To determine the Schwann cell-derived molecules which may
be involved in mediating the inflammatory response, we re-
examined a microarray analysis performed on NSRafER cells
(Parrinello et al., 2008) and found that a number of mRNAs
encoding secreted factors were upregulated following Raf acti-
vation in dedifferentiated Schwann cells (Table 1). These in-
cluded cytokines, some of which had been previously implicated
in attracting inflammatory cells following nerve trauma such
as the c-kit ligand and MCP-1 (Perrin et al., 2005; Toews et al.,
1998; Tofaris et al., 2002) but also many others not previously734 Neuron 73, 729–742, February 23, 2012 ª2012 Elsevier Inc.reported in injured nerves—such as IL11, Scye1
and Cxcl10 (Table 1). Interestingly, a number of
other factors likely to be important in the regen-
erative response, such as MEGF10—an engulf-
ment receptor implicated in the phagocytosis
of myelin debris (MacDonald et al., 2006), neu-
ronal growth factors such as GDNF, and blood
vessel growth factors (VEGFA and C) were
also strongly upregulated. Importantly, the up-
regulation of many, but not all, of these genes
in vivo was confirmed by qRT-PCR analysis
(Figure 6B). Moreover, analysis of CM from
NSRafER cells using a rat cytokine antibody
array showed that the cytokines on the array,which were upregulated in the microarray analysis (MCP-1,
VEGF, and TIMP-1), were also found at increased levels in the
CM, confirming that the increase in mRNA is accompanied by
a corresponding increase in cytokine production (Figure S6B).
The majority of the cytokines on the antibody array, however,
were not upregulated in the microarray analysis and we could
not detect increased levels of these cytokines in the CM
indicating a specificity of the response. The one exception was
PDGF-AA, which was not upregulated in the microarray analysis
but was found at slightly higher levels in the CM and in vivo. It will
be of great interest to explore the role of these candidates in the
regenerative process.
The PNS is a privileged environment maintained by the BNB.
Breakdown of the BNB is thought to be required for the robust
inflammatory response that occurs following nerve injury (Weer-
asuriya, 1988). To test the effects of activation of the ERK sig-
naling pathway in Schwann cells on the BNB, we injected WT
or P0-RafTR mice with Evans blue, a tracer that passes from
blood vessels into the endoneurium and perineurium following
breakdown of the BNB. In WT animals, the dye was restricted
from the inner spaces of the sciatic nerve (Figure 6C). In contrast,
in P0-RafTR animals, breakdown of the BNB was observed as
early as day 4, with complete breakdown by day 5, coincident
with the increased numbers of inflammatory cells found within
Figure 6. Dedifferentiated Schwann Cells Secrete
Factors that Recruit Inflammatory Cells
(A) Conditioned medium from Schwann cells expressing
the RafTR (NSRafER) pretreated for 48 hr with ethanol
(EtOH), Tmx, Tmx plus the MEK inhibitor (PD184352), or
control medium (Neg CTRL) was incubated in the bottom
of duplicate transwells. Left panel: purified rat white blood
cells were added to the upper wells. Two hours later,
migrated cells were collected and counted by FACS. 10%
Zymosan-activated serum (ZAS) was used as a positive
control. Right panel: primary rat fibroblasts were added to
the upper wells. 7 hr later, cells on the upper surface were
removedmechanically and cells that hadmigrated into the
lower surface were counted. 10% fetal bovine serum
(FBS) was used as a positive control. Results are ex-
pressed as mean relative to control medium and are the
average of 3 experiments ± SEM.
(B) qRT-PCR of RNA from sciatic nerves of WT and P0-
RafTR mice after 72 hr of daily tamoxifen injections. The
bar graphs represent the relative levels of indicated genes
(n = 4 animals for each group, ± SEM).
(C) Evans blue dye was injected into WT and P0-RafTR
mice 30 min before sacrifice at the indicated times fol-
lowing the first Tmx injection. Representative fluorescent
images of sciatic nerve cross-sections from WT and P0-
RafTR mice are shown (three animals at each time point
were analyzed and all animals responded similarly).
See also Figure S6.
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Raf/MEK/ERK Drives Schwann Cell Demyelinationthe nerve (Figures 5 and 6C). These results indicate that
breakdown of the BNB can be triggered by Raf-activated signals
from Schwann cells independent of trauma.
These findings show that that the activation of the ERK-
signaling pathway in myelinating Schwann cells is sufficient to
drive both demyelination and the inflammatory response with
important implications for pathologies such as inflammatory
neuropathies. To test the requirement of this pathway follow-
ing injury, we used the highly-selective MEK1/2 inhibitorNeuron 73, 729PD0325901 (Solit et al., 2006) to block the
increase in ERK signaling seen in Schwann cells
following nerve injury compared to the vehicle-
treated controls. In initial experiments, we found
that treatment of themice reduced P-ERK levels
dramatically as detected by both western blot
and immunostaining (Figures S7A and S7B),
although we were unable to block the pathway
completely. In contrast, levels of P-JNK re-
mained constant (Figure S7A). Despite this, we
observed a dramatic inhibition of both Schwann
cell dedifferentiation and the inflammatory re-
sponse in the PD0325901 treated animals fol-
lowing nerve injury even though the axons
degenerated similarly in the two conditions (Fig-
ure S7B). qRT-PCR analysis of the expression of
themyelin genesP0, periaxin, andMBP showed
there was a strong delay in the downregulation
of these genes and a significant decrease in
the level of inhibition in the PD0325901-treated
animals (Figure 7A). Furthermore, we also saw
a slight upregulation of some of these genesprior to injury consistent with the ERK pathway acting as a nega-
tive regulator of their expression. Moreover, there was a corre-
sponding delay and inhibition of the upregulation of markers
for the progenitor-like Schwann cells. Consistent with the inhibi-
tion of the transcriptional program associated with the switch in
Schwann cell-state, we observed a dramatic difference in the
structure of the nerves following injury (Figures 7B and S7C).
Together, these results show that the ERK pathway is important
in driving the rapid dedifferentiation of Schwann cells following–742, February 23, 2012 ª2012 Elsevier Inc. 735
Table 1. Fold Increase in the RNA Levels of Selected Transcripts following Raf Activation in Schwann Cells
Gene Name Fold Change p Value
Neurite Outgrowth
Alcam Activated leukocyte cell adhesion molecule 12.31 1.31E-04
Boc_predicted Biregional cell adhesion molecule-related, downregulated by oncogenes (Cdon),
binding protein
2.96 3.46E-04
Gdnf Glial cell derived neurotrophic factor 2.42 2.41E-03
Itga7 Integrin alpha 7 2.43 4.78E-03
Sema3a Sema domain, immunoglobulin domain (Ig), short basic domain, secreted,
(semaphorin) 3A
4.97 3.85E-04
Sgk Serum/glucocorticoid-regulated kinase 1 3.10 2.04E-04
Phgdh Similar to 3-phosphoglycerate dehydrogenase; phosphoglycerate
dehydrogenase
2.42 2.99E-04
Slit3 Slit homolog 3 (Drosophila) 2.04 4.11E-03
Spon1 Spondin 1 16.93 8.03E-04
Angiogenesis
Scg2 Secretogranin II (chromogranin C) 16.30 2.96E-04
Vegfa Vascular endothelial growth factor A 2.13 9.82E-05
Vegfc Vascular endothelial growth factor C 10.65 1.57E-05
SC Migration
Cd44 Cd44 molecule 2.44 1.60E-04
Cdh2 Cadherin 2 3.36 7.13E-04
Cfl1 Cofilin 1, nonmuscle; similar to Cofilin-1 (cofilin, nonmuscle isoform) 1.94 1.95E-04
RGD1306694_predicted Coiled-coil domain containing 88A 1.81 7.13E-04
Coro1a Coronin, actin-binding protein 1A 2.72 7.65E-04
Gja1 Gap junction protein, alpha 1 65.95 2.23E-08
Itga3_predicted Integrin alpha 3 4.28 1.78E-05
Kbtbd10 Kelch repeat and BTB (POZ) domain containing 10 3.04 1.67E-05
Msn Moesin 1.97 5.44E-05
Podxl Podocalyxin-like 1.96 9.69E-04
Ptprm Protein tyrosine phosphatase, receptor type, M 3.45 1.35E-06
Scarb1 Scavenger receptor class B, member 1 2.27 4.79E-03
Tgfb1 Transforming growth factor, beta 1 4.41 1.59E-05
Tiam1_predicted T-cell lymphoma invasion and metastasis 1 (predicted) 2.43 8.43E-06
Tnfrsf12a Tumor necrosis factor receptor superfamily, member 12a 2.89 2.13E-05
Vasp_predicted Vasodilator-stimulated phosphoprotein 1.92 5.44E-04
Cspg2 Versican 3.61 7.95E-04
SC Proliferation
Calca Calcitonin/calcitonin-related polypeptide, alpha 9.74 1.35E-05
Plau Plasminogen activator, urokinase 3.11 1.72E-03
Unc5b Unc-5 homolog B (C. elegans) 5.87 8.75E-07
Tgfb1 Transforming growth factor, beta 1 4.41 1.59E-05
Tissue Remodeling
Dtr Heparin-binding EGF-like growth factor 12.94 4.48E-05
Fgf2 Fibroblast growth factor 2 8.31 4.44E-07
Fbln1_predicted Fibulin 1 (predicted) 4.32 6.68E-06
Hmox1 Heme oxygenase (decycling) 1 3.19 1.55E-05
Jag1 Jagged 1 7.43 5.24E-07
Mmp16 Matrix metalloproteinase 16 4.21 1.42E-03
Pthlh Parathyroid hormone-like peptide 3.96 3.93E-04
Ptprm Protein tyrosine phosphatase, receptor type, M 3.45 1.35E-06
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Table 1. Continued
Gene Name Fold Change p Value
Sdc1 Syndecan 1 41.23 5.48E-08
Spp1 Secreted phosphoprotein 1 2.12 3.32E-04
Tnfrsf11b Tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) 14.10 2.09E-06
Inflammation
Areg Amphiregulin 45.49 3.99E-07
Ccl2 (MCP1) Chemokine (C-C motif) ligand 2 30.23 5.86E-07
Cxcl10 Chemokine (C-X-C motif) ligand 10 3.81 8.49E-07
Il11 Interleukin 11 4.86 3.04E-04
Kitl Kit ligand 2.54 5.51E-03
Mif Macrophage migration inhibitory factor 3.95 4.79E-06
Mmp14 Matrix metalloproteinase 14 (membrane-inserted) 1.80 6.85E-04
Megf10 Megf10 protein 14.55 2.08E-05
Plau Plasminogen activator, urokinase 3.11 1.72E-03
Scye1 Small inducible cytokine subfamily E, member 1 1.71 6.41E-04
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proliferative and inflammatory responses to nerve injury. For
these experiments, we decided to perform a nerve crush rather
than a transection and examined the nerves distal to the site of
injury in order to minimize the inflammatory response directly
caused by the trauma of the surgery. Analysis of the nerves
showed that the MEK inhibitor blocked the increase in cell
number seen following nerve injury and consistent with this, we
observed a dramatic reduction of EdU-positive cells (Figures 7C,
7D, and S7D). Moreover, consistent with our in vitro studies (Fig-
ure 6A), there was a strong decrease in the number of inflamma-
tory cells recruited into the nerve of PD0325901-treated mice
compared to vehicle-treated controls (Figure 7E), consistent
with the ERK pathway having an important role in the recruitment
of inflammatory cells following nerve injury.
Continued observation of the P0-RafTR mice indicated that
from day 10, the motor function of the mice progressively recov-
ered and that by day 30 the mice performed asWT controls (Fig-
ure 8A and Movie S3). Analysis of the levels of ERK activation
following the final injection on day 5 showed a strong decrease
in P-ERK levels by day 10, with the levels back to control by
day 14 (Figures S8A and S8B). Consistent with this, Schwann
cell proliferation was also low by day 10 (Figure 4C). When the
nerve histology was analyzed ‘‘postrecovery’’ on day 90, there
was extensive remyelination (Figure 8B) and a dramatic reduc-
tion in p75 staining indicating a switch-back to the myelinated
state (Figure 8C). Moreover, the numbers of inflammatory cells
had largely returned to control levels (Figure 8D) and the BNB
was restored (not shown). Nevertheless, the nerves were clearly
distinct from control nerves (Figure 8B), in that many axons
appeared to have thicker myelin sheaths and the ratio of axon
diameter to myelin thickness showed greater heterogeneity
than control nerves (Figure S8C). However, the recovered nerves
were also clearly distinct from nerves that had regenerated
following nerve transection, in which the number of axons per
field was greatly increased, reflecting the axonal sprouting
which takes place during axonal regrowth (Figure S8C); more-
over, areas containing minifascicular structures were frequentlyobserved—as by others (Bradley et al., 1998)—but were never
seen in the recovered P0-RafTR nerves.
These results indicate that activation of ERK signaling in
myelinating Schwann cells drives themback to a dedifferentiated
state despite the presence of signals from intact axons. How-
ever, as soon as the ERK signal diminishes, these dedifferenti-
ated Schwann cells are able to rapidly redifferentiate in response
to axonal signals (Michailov et al., 2004; Sherman and Brophy,
2005; Taveggia et al., 2005). This would indicate that in the pres-
ence of axons, the period of dedifferentiation is solely controlled
by the duration of the ERK signal. To test this, we added a second
set of three daily tamoxifen injections, starting on day 14 to
prolong the period of ERK activation and found that this resulted
in a longer period of motor function loss (Figure 8A). Interestingly
however, the mice recovered with similar kinetics indicating that
Schwann cell dedifferentiation can be maintained by continual
signaling through the ERK signaling pathway and that on the
removal of the signal the Schwann cells are able to respond to
the axonal signals and redifferentiate.
DISCUSSION
The repair of injured peripheral nerves involves the coordinated
action of multiple cell types. The normal initiator of this injury
response is a signal from damaged axons warning of their in-
tention to degenerate. This rapid, currently unknown, signal is
detected by Schwann cells and interpreted as an instruction to
dedifferentiate to a progenitor-like cell. While the remarkable
plasticity of the Schwann cell in response to nerve damage has
been extensively reported, the signaling events that control the
switch in cell state remain poorly understood. Moreover, the
overall role of progenitor-like Schwann cells in the regeneration
process remains unclear. In this study, we have developed a
mouse model in which we can specifically activate the Raf/
MEK/ERK signaling pathway in myelinating Schwann cells and
show that activation of this single pathway is sufficient to initiate
the dedifferentiation process and uncovering a central role for
the Schwann cell in orchestrating the repair response.Neuron 73, 729–742, February 23, 2012 ª2012 Elsevier Inc. 737
Figure 7. Inhibition of ERK Signaling Delays
Schwann Cells Dedifferentiantion, Demye-
lination, and Induction of the Inflammatory
Response that Follows Nerve Injury
(A) qRT-PCR of RNA from cut sciatic nerves
of PD0325901 (PD cut)- or vehicle (DMSO cut)-
treated mice. Three different time points are
shown. The bar graphs represent the relative levels
of indicated genes (n = 3 animals for each
group ± SEM).
(B) Representative cross-sections of the distal
regions of crushed sciatic nerves of PD0325901
(PD)- or vehicle (DMSO)-treated mice stained for
P0 48 hr after crush (upper panels) or semi-thin
cross-sections 72 hr after crush (lower panels).
Scale bar 10 mm. Right panel: quantification of
degenerated myelin fibers in PD or DMSO treated
mice 72 hr after crush (n = 4 animals for each
group, 3 different fields were counted for each
animal, data are represented as mean values ±
SEM). For details of Mild and Severe phenotypes,
see Figure S7C.
(C) Cryosections of uninjured or crushed sciatic
nerves of PD0325901 (PD)- or vehicle (DMSO)-
treated mice were stained with Hoechst to label all
the cells. Graph shows quantification of nuclei in
the distal region of the nerves uninjured or 72 hr
after crush.
(D) PD0325901 (PD)- or vehicle (DMSO)-treated
mice were injected with EdU, 4 hr prior to sacri-
fice. Quantification of the percentage of EdU-
positive cells and the percentage of EdU-positive
cells that are P75 positive (proliferating Schwann
cells) in the distal nerve 72 hr following crush.
(E) Quantification of macrophages (Iba1), T cells
(CD3), neutrophils (NIMP-R14), and mast cells
(CD117) in the distal region of crushed nerves
from PD0325901 (PD)- or vehicle (DMSO)-treated
mice at 72 hr. (For C–E, n = 3 animals for each
group at each time point, 10 different fields for
each animal were counted, data are represented
as mean values ± SEM).
See also Figure S7.
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damage with a strong, sustained activation of the ERK signaling
pathway (Harrisingh et al., 2004). In the present study, we have
overridden this sensing mechanism by activating this pathway
in the absence of axonal damage. This drives the dedifferentia-
tion process, demonstrating that sustained Raf/MEK/ERK sig-
naling is sufficient to drive this switch in cell state and that it
can act dominantly over any prodifferentiating signals provided
by intact axons. This dominant control of cell state by Raf kinase
is further demonstrated by the finding that prolonging ERK
signaling maintains the dedifferentiated state, with the Schwann
cells only responding to the prodifferentiating signals from axons
once the level of ERK signaling declines. Importantly, the revers-
ibility of these studies also showed that prodifferentiation signals
are retained by axons in the adult, as the Schwann cells rapidly
drop out of the cell cycle and redifferentiate once the ERK signal738 Neuron 73, 729–742, February 23, 2012 ª2012 Elsevier Inc.declines. Similarly to our in vitro results and consistent with other
studies (Jessen and Mirsky, 2008), this change in cell state is
reflected by a change in the transcriptional program of the
Schwann cell. We find that this transcriptional response is rela-
tively rapid, similar to that following injury and precedes any
changes in the structure of the nerve, arguing that the transcrip-
tional changes induced by Raf activation are driving the switch in
cell state. This reprogramming of gene expression is followed
by a slower breakdown of the myelin structure, presumably
because of the relative stabilities of the proteins making up the
myelin sheath, which may be enhanced by the integrity of the
axons. Recent work has highlighted the role of the transcriptional
regulators c-Jun and Notch (ICD) in the demyelination program
initiated by nerve injury (Parkinson et al., 2008; Woodhoo et al.,
2009). Interestingly, we find that c-Jun and the Notch ligand
jagged-1 are strongly upregulated following Raf activation in
Figure 8. Remyelination and Behavioral Recovery
of P0-RafTR Mice following the Cessation of Raf
Signaling
(A) WT and P0-RafTR adult mice were tested on an
accelerating rotarod for a maximum of 300 s at the indi-
cated days using the two different tamoxifen injection
protocols indicated. Mean latency to fall (±SEM) is plotted
(n = 10 animals for each group).
(B) Representative phase microscopy images of semi-thin
cross-sections of sciatic nerve stained with toluidine blue;
Left panel: from WT and P0-RafTR mice 90 days after the
first tamoxifen injection. Right panel: from the distal stump
of ‘‘cut’’ WT nerve allowed to regenerate for 90 days. Scale
bar is 20 mm.
(C) Cryosections of WT and P0-RafTR mice at day 90
stained with Hoechst (blue) and the Schwann cell marker
p75 (green). Scale bar is 250 mm.
(D) Quantification of cell numbers from day 90 WT
and recovered P0-RafTR nerves relative to day 10 values,
expressed as a percentage. Data were obtained from
analysis of cryosections labeled with Hoechst together
with the antibodies to the indicated cell markers: p75
(dedifferentiated/nonmyelinating Schwann cells), Iba1
(macrophages), CD117 (mast cells), NIMP-R14 (neutro-
phils), and CD3 (T cells) (n = 3 animals for each group at
each time point, 8 different fields from each animal were
counted, data are represented as mean values ± SEM).
See also Figure S8 and Movie S3.
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and the Notch pathway downstream of the ERK signaling
pathway. It will be of great interest to further explore the relative
roles of these and other transcription factors in this remarkable
switch in cell state.
Part of the dedifferentiation response includes the induction of
multiple genes that are potential mediators of the inflammatory
response that follows activation of Raf in Schwann cells. In
many aspects, this inflammatory response mirrors the response
following nerve injury, indicating that Schwann cells are key
mediators of this process—the influx of the inflammatory cells
shows similar kinetics and the types of cells appear the same
(Hall, 2005). This would seem to make biological sense—
Schwann cells are early detectors of the damage signal, remain
in the environment during the clearance and regenerationNeuron 73, 729process, and redifferentiate to complete the
repair and should thus be capable of initiating,
maintaining, and limiting the inflammatory re-
sponse. Our findings, that CM from Raf-acti-
vated Schwann cells is capable of attracting
the white blood cells which we find in the nerve
argues that this effect is direct. Some of these
factors have been previously reported, such
as MCP-1, which is thought to be important,
although not the only factor responsible, for
macrophage activation and recruitment (Fischer
et al., 2008; Groh et al., 2010; Martini et al.,
2008; Toews et al., 1998; Tofaris et al., 2002).
In future studies, it will be important to investi-
gate the roles of the other proteins identified in
our studies on the inflammatory response.It is interesting to speculate on the advantages of having
Schwann cells coordinate this inflammatory response. The
repair that occurs following peripheral nerve injury requires the
coordination of multiple processes. At the site of injury, there is
a classical wound-healing response, with the recruitment of
inflammatory cells and fibroblasts, both of which are important
in repairing the physical damage and defending the area from
infection. However, the response to this wound has conse-
quences far, sometimes more than a meter, from the initial site
of injury and requires a distinct response, including the break-
down and clearance of axons downstream of the cut and
the development of an environment suitable for regeneration.
Although this response includes breakdown of the BNB and
the influx of inflammatory cells, the major role of these cells is
tissue remodeling rather than dealing with tissue trauma and–742, February 23, 2012 ª2012 Elsevier Inc. 739
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nals and control mechanisms (Medzhitov, 2010). This view is
corroborated by studies which have shown a distinct role for
B cells in nerve regeneration—in that antibodies directed to
myelin debris are crucial for the efficiency of the clearance
process (Vargas et al., 2010). Our data show that Schwann
cells instigate an inflammatory response via the secretion of a
specific subset of cytokines. Analysis of this response compared
to that elicited following trauma or infection may be useful to
determine the different inflammatory responses to these distinct
triggers.
Consistent with these ideas, an important distinction between
the Raf-induced inflammatory response and the response
following nerve trauma was the lack of a detectable fibroblast
response. Following nerve crush or transection, large numbers
of fibroblasts are found in the nerve. Moreover, as the nerve
regenerates, fibroblasts are involved in tissue restructuring,
forming compartmentalized units called minifascicles, which
are thought to provide a protected microenvironment for the
regrowing axons (Figure 8B; Morris et al., 1972). The lack of
a detectable fibroblast response in the P0-RafTR nerves argues
that Raf-mediated Schwann cell signals are not involved in
controlling the behavior of these fibroblasts during the repair
process. Consistent with this, we find that large numbers of
fibroblasts tend to be restricted to the wound site (Parrinello
et al., 2010), suggesting that signals associated with the
damaged tissue are mediating this response. This also suggests
that either trauma or axonal damage/regrowth is necessary for
the formation of minifascicles, as these structures are never
observed in the P0-RafTR mice.
Following nerve injury, in contrast to the P0-RafTR mouse,
the axons degenerate and inflammation will occur as a direct
response to the surgery and trauma. To determine the role of
the MEK/ERK signaling pathway following injury, we treated
mice with the MEK inhibitor and observed a dramatic inhibition
in the kinetics in the switch in Schwann cell differentiation state
and the inflammatory response. These results are consistent
with our in vitro studies showing that MEK inhibitors are able to
block Schwann cell dedifferentiation (Harrisingh et al., 2004)
and the inflammatory response (Figure 6A). While these results
indicate an important role for this pathway in both of these
responses, we were unable to block the response completely.
This may be due to our inability to completely block the pathway
(we were unable to use higher concentrations of the inhibitor or
treat for longer times due to toxicity in other tissues), a contribu-
tion of other pathways, or the loss of axonal prodifferentiating
signals. However, they are consistent with an important role for
this pathway both in the rapidity of the switch in Schwann
cell state and the inflammatory response and moreover dem-
onstrate the possibility of an approach for the treatment of dis-
orders of the PNS, in particular inflammatory peripheral neu-
ropathies. Future experiments using conditional knockouts of
the ERK pathway should provide complementary information
on the role of this pathway in the response and repair of periph-
eral nerves following injury.
Neurofibromas develop following loss of neurofibromin ex-
pression in Schwann cells. We have previously shown that NF1
loss is sufficient to disrupt Schwann cell/axonal interactions740 Neuron 73, 729–742, February 23, 2012 ª2012 Elsevier Inc.in vitro as a result of elevated signaling through the Raf/MEK/
ERK pathway and that this pathway blocks Schwann cell differ-
entiation (Harrisingh et al., 2004; Parrinello et al., 2008). How-
ever, a recent flurry of in vivo studies in mice has demonstrated
that Schwann cells engineered to lose NF1 expression during
development differentiate normally (Joseph et al., 2008; Wu
et al., 2008; Zheng et al., 2008). This suggested that either
increased Raf/MEK/ERK signaling is unable to block Schwann
cell differentiation in vivo or that during development this
pathway does not get sufficiently activated in NF1/ Schwann
cells. Our results indicate the latter, as we show that Raf/MEK/
ERK signaling is sufficient to both drive the efficient dedifferenti-
ation of Schwann cells in normal nerve and that continual ERK
signaling maintains them in this dedifferentiated state. It will be
of great importance to determine the mechanisms by which
ERK signaling is suppressed during development to allow myeli-
nation to proceed in NF1-deficient Schwann cells but can be
triggered in adulthood to initiate neurofibroma development.
Interestingly, a recent study has found that there is a requirement
for ERK signaling at an early stage of Schwann cell differentiation
during normal development (Newbern et al., 2011). Our results
would suggest that the environment that permits NF1/ cells
to differentiate would also need to be acting during normal devel-
opment to suppress this early signal. Another possibility is that it
may indicate that different levels of ERK signaling have opposing
effects on the differentiation process. This could be reminiscent
of the dual role of neuregulin signaling in the control of Schwann
cell myelination and demyelination (Syed et al., 2010). Consistent
with this idea, P-ERK levels are extremely high and are main-
tained at this high level for several days in Schwann cells fol-
lowing nerve injury. The inducible, titratable nature of our mouse
model may make it a useful system for studying further how
differential activation of this pathway can affect Schwann cell
differentiation state in vivo both during development and in the
adult.
The results of this study also have potential significance
for certain peripheral neuropathies, particularly those in which
both demyelination and inflammation are observed. Elevated
ERK signaling has been implicated in these disorders, making
it likely that some aspects of the inflammatory response in these
neuropathies are triggered by signals emanating from dediffer-
entiated Schwann cells (Kohl et al., 2010; Nadra et al., 2008;
Tapinos et al., 2006). As these diseases progress, there tends
to be increasing axonal damage (Nave, 2010). It is noteworthy
that, at least in the short-term, there is no axonal damage asso-
ciated with either the demyelination or the inflammatory re-
sponse in the tamoxifen-injected P0-RafTR mouse. This is con-
sistent with the view that Schwann cells provide trophic support
to axons irrespective of their differentiation state (Nave, 2010)
and that certain injuries can induce focal demyelination without
associated axonal injury (Zochodne, 2008). However, it does
suggest that the damage to axons seen in the disease states is
either the result of a more prolonged response or requires addi-
tional factors. In any case, our findings that the Raf/MEK/ERK
signaling pathway drives both the demyelination of peripheral
nerves and the associated inflammatory response, together
with the observations that recovery takes place when the signal
is switched off indicate that inhibitors to this pathway or
Neuron
Raf/MEK/ERK Drives Schwann Cell Demyelinationdownstream of this pathway may be useful therapeutics for the
treatment of PNS neuropathies and tumors.
EXPERIMENTAL PROCEDURES
Generation of RafTR Transgenic Mice
The RafTR coding sequence was amplified by PCR from the vector pLXSN3-
RAFTR using the forward 50-CATTCCATGGAGTACTCACAGCCG-30 and
reverse primers 50-CGATGACGTCAGATCGTGTTGGGGAAGC-30, respec-
tively. The resulting 2.2kb fragment was cloned directly into the AatII site
of P0Cx32-Nco-Myc-Aat (A kind gift from Steven Scherer and John
Bermingham, Jr.) following removal of the Myc-Tag ATG in the NcoI site. The
vector backbone of P0Cx32-RafTR was removed using EcoRI/HindIII and the
7 kb fragment containing P0Cx32-RafTRwas then used for pronuclear injection
in C56BL6/J, which were then crossed and maintained on a B6CBAF1/J back-
ground. Genotyping of the RafTR transgene were performed using the primers
(RafTR: 50-GCAGCCCACACTGAGGATA-30, 50-AAGGACAAGGCAGGGCTA
TT-30, hRaf1: 50-ACCCATTCAGTTTCCAGTCG-30, 50-GCTACCAGCCTCTTCA
TTGC-30). For details of tamoxifen injections and Evans blue injections, see
Supplemental Experimental Procedures. All animal work was carried out in
accordance with the guidelines and regulations of the Home Office.
Protein Analysis
For antibody, immunofluorescence and western blotting details see Supple-
mental Experimental Procedures.
Quantitative PCR
See Supplemental Experimental Procedures.
Microarray Analysis
The microarray analysis described previously in Parrinello et al. (2008)
analyzed changes in RNA levels in NSRafER cells following 24 hr of Raf activa-
tion. Genes associated with distinct processes likely to be involved in nerve
repair were identified using a combination of DAVID analysis (Huang et al.,
2009) and manual identification. Relevant genes are expressed in Table 1.
Fold change represents the level of induction following Raf activation
compared to cells treated with control solvent and the associated p value is
shown.
Cell Proliferation and Migration Analysis
See Supplemental Experimental Procedures.
Motor Coordination
Male mice (n = 10) were tested using the accelerating Rotarod. Rotarod speed
was increased from 5 to 50 rpm over a 5 min period and the latency to fall was
recorded. Twenty-four hours prior to each recording mice were subjected to 3
training trials, with a 20 min interval, in order to familiarize themwith the proce-
dure. During testing, three trials were recorded at each time point for each
mouse.
Light and Electron Microscopy
Sciatic nerves were fixed with 2% glutaraldehyde in 0.2 M phosphate buffer
O/N at 4C, postfixed in osmium tetroxide for 1.5 hr at 4C and then in 2%
uranyl acetate for 45 min at 4C. Nerves were then dehydrated in an ethanol
series before embedding in epoxy resin. Semithin sections were cut with
a glass knife at 0.3 mm and stained with 1% toluidine blue in 2% borax at
75C for 2 min. Ultrathin sections were cut with a diamond knife at 70 nm,
collected onto formvar coated slot grids and then visualized using transmis-
sion electron microscopy.
Statistical Analysis
The data are represented as mean values plus/minus standard error of the
mean. Unpaired two-tailed Student’s t test was used for statistical analysis
and p values considered significant were indicated by asterisks as follows:
*p < 0.05, **p < 0.01, ***p < 0.001.SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, three movies, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.neuron.2011.11.031.
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